Patents Assigned to Carrus Capital Corporation
  • Antimicrobial and anti-inflammatory peptides
    Patent number: 9872885
    Abstract: Antimicrobial and/or anti-inflammatory peptide compositions and therapeutic uses thereof are provided. The peptides and analogs or derivatives thereof may be used as an antimicrobial agent and/or as an anti-inflammatory agent. In certain embodiments, the peptides are cationic peptides. The peptides are useful for the treatment of inflammatory diseases, such as microorganism-caused infections, acne, and psoriasis. The peptides and peptide formulations may be used topically or parenterally.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: January 23, 2018
    Assignee: CARRUS CAPITAL CORPORATION
    Inventors: Patricia J. McNicol, Sonia K. Pawlak, Evelina Rubinchik, Dale Cameron, Maria Marta Guarna, Janet R. Fraser, Shafique Fidai, Yuchen Chen, Timothy J. Krieger
  • Antimicrobial cationic peptides and formulations thereof
    Patent number: 9227999
    Abstract: Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: January 5, 2016
    Assignee: Carrus Capital Corporation
    Inventors: Timothy J. Krieger, Patricia J. McNicol
  • ANTIMICROBIAL CATIONIC PEPTIDES AND FORMULATIONS THEREOF
    Publication number: 20150087580
    Abstract: Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device.
    Type: Application
    Filed: November 26, 2014
    Publication date: March 26, 2015
    Applicant: Carrus Capital Corporation
    Inventors: Timothy J. KRIEGER, Patricia J. McNicol
  • Antimicrobial and anti-inflammatory peptides
    Patent number: 8933029
    Abstract: Antimicrobial and/or anti-inflammatory peptide compositions and therapeutic uses thereof are provided. The peptides and analogs or derivatives thereof may be used as an antimicrobial agent and/or as an anti-inflammatory agent. In certain embodiments, the peptides are cationic peptides. The peptides are useful for the treatment of inflammatory diseases, such as microorganism-caused infections, acne, and psoriasis. The peptides and peptide formulations may be used topically or parenterally.
    Type: Grant
    Filed: August 26, 2002
    Date of Patent: January 13, 2015
    Assignee: Carrus Capital Corporation
    Inventors: Patricia J. McNicol, Sonia K. Pawlak, Evelina Rubinchik, Dale Cameron, Maria Marta Guarna, Janet R. Fraser, Shafique Fidai, Yuchen Chen, Timothy J. Krieger
  • Antimicrobial cationic peptides and formulations thereof
    Patent number: 8927487
    Abstract: Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: January 6, 2015
    Assignee: Carrus Capital Corporation
    Inventors: Timothy J. Krieger, Patricia J. McNicol
  • Antimicrobial cationic peptides and formulations thereof
    Patent number: 8466102
    Abstract: Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device.
    Type: Grant
    Filed: March 15, 2012
    Date of Patent: June 18, 2013
    Assignee: Carrus Capital Corporation
    Inventors: Timothy J. Krieger, Patricia J. McNicol
  • ANTIMICROBIAL CATIONIC PEPTIDES AND FORMULATIONS THEREOF
    Publication number: 20120202735
    Abstract: Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device.
    Type: Application
    Filed: March 15, 2012
    Publication date: August 9, 2012
    Applicant: Carrus Capital Corporation
    Inventors: Timothy J. Krieger, Patricia J. McNicol
  • Antimicrobial cationic peptides and formulations thereof
    Patent number: 8138144
    Abstract: Compositions and methods for making and using therapeutic formulations of antimicrobial cationic peptides are provided. The antimicrobial cationic peptide formulations may be used, for example, in the treatment of microorganism-caused infections, which infections may be systemic, such as a septicemia, or may be localized, such as in acne or an implanted or indwelling medical device.
    Type: Grant
    Filed: June 10, 2004
    Date of Patent: March 20, 2012
    Assignee: Carrus Capital Corporation
    Inventors: Timothy J. Krieger, Patricia J. McNicol